After a hiatus because of the COVID-19 pandemic, the IPO market has come roaring back. Just look at yesterday’s offering for Lemonade (NYSE:LMND). The shares spiked by 139% to $69.41—putting the market cap at over $3 billion.
Read more here.
After a hiatus because of the COVID-19 pandemic, the IPO market has come roaring back. Just look at yesterday’s offering for Lemonade (NYSE:LMND). The shares spiked by 139% to $69.41—putting the market cap at over $3 billion.
Read more here.
![[Alpha Tau in PR Newswire] Alpha Tau announces results of first US clinical trial of Alpha DaRT™ in malignant skin & soft tissue cancers, showing complete response in all ten treated tumors at approximately 12 weeks and no product-related serious adverse events](https://blog.gold.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
